GGrantIndex
Sort

34,240 grants matching atherosclerosis

Serum Amyloid and Inflammation in Atherogenesis

$474,640
Alan Chait · University Of Washington · P01 · FY2009 · HL

Molecular Regulation of Cardiovascular 7 TM Receptors

$474,580
Robert J Lefkowitz · Duke University · R01 · FY2010 · HL

Regulation of B-arrestin2's pro-atherogenic activity by the deubiquitinase USP20

$474,576
Sudha K Shenoy · Duke University · R01 · FY2014 · HL

Subclinical Renal Artery Atherosclerosis, Kidney Function and Hypertension

$474,562
Matthew A Allison · University Of California, San Diego · R01 · FY2009 · DK

CONTROL OF LP(A) IN VITRO

$474,562
University Of Calif-Lawrenc Berkeley Lab · R01 · FY2000 · HL

Risk prediction of atrial fibrillation: clinical, biological and genetic markers

$474,529
Emelia J. Benjamin · Boston University Medical Campus · RC1 · FY2010 · HL

Is mental disorder a preventable cause of age-related disease? The Dunedin Study.

$474,521
Terrie Edith Moffitt · Duke University · R01 · FY2012 · AG

Novel Pathways for Triglyceride Storage and Adipogenesis

$474,394
Peter J Tontonoz · University Of California Los Angeles · P01 · FY2010 · HL

The Lipid Protein Family and Triglyceride Metabolism

$474,394
Karen Reue · University Of California Los Angeles · P01 · FY2010 · HL

Project 2: Regulation of lipid and glucose metabolism by ANGPTL3 in humans

$474,343
Nathan Oliver Stitziel · University Of Washington · P01 · FY2021 · HL

Project 2: Regulation of lipid and glucose metabolism by ANGPTL3 in humans

$474,337
Nathan Oliver Stitziel · University Of Washington · P01 · FY2022 · HL

Role of SuPAR in the Intersection between Cardiovascular and Kidney Disease

$474,300
Salim Hayek · University Of Michigan At Ann Arbor · R01 · FY2023 · HL

Prothrombin Gene Variation and the Risk of SLE and CHD

$474,249
M. Ilyas Kamboh · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · HL

Control of Endothelial Mechanotransduction by the Mitochondrial Ca2+ Uniporter: Implications for Atherosclerosis

$474,184
Barbara Rita Alevriadou · Ohio State University · R01 · FY2018 · HL

Isoprostane Products and HDL Dysfunction

$474,173
L Jackson Roberts · Vanderbilt University · P01 · FY2014 · HL

Cardiovascular Epidemiology Training Grant

$474,095
Wayne D. Rosamond · Univ Of North Carolina Chapel Hill · T32 · FY2015 · HL

Depression and Coronary Artery Atherosclerosis in Premenopausal

$474,077
Carol A. Shively · Wake Forest University Health Sciences · R01 · FY2008 · HL

Prevention of type 2 diabetes

$474,074
William C Knowler · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK

Mechanisms of myelopoiesis after myocardial infarction

$474,057
Partha Dutta · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · HL

Mechanisms of myelopoiesis after myocardial infarction

$474,057
Partha Dutta · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · HL

Targeting the relief of chronic pain with orally active peroxynitrite decompositi

$474,025
William Neumann · Southern Illinois Univ At Edwardsville · RC1 · FY2010 · AR

Training in Advanced Heart Disease Research

$474,002
Eduardo Marban · Cedars-Sinai Medical Center · T32 · FY2019 · HL

Insulin Signaling And Gene Regulation In Transfected Adipose Cells

$474,000
Michael J. Quon · National Center For Complementary & Integrative Health · Z01 · FY2008 · AT

Project 3: Microbiota generated aryl sulfates and secondary bile acids in cardiometabolic disease

$473,989
Michael Andrew Fischbach · Cleveland Clinic Lerner Com-Cwru · P01 · FY2020 · HL

Project 3: Microbiota generated aryl sulfates and secondary bile acids in cardiometabolic disease

$473,989
Michael Andrew Fischbach · Cleveland Clinic Lerner Com-Cwru · P01 · FY2021 · HL